Angiogenesis and the persistence of inflammation in a rat model of proliferative synovitis.
Ashraf
Sadaf
S
Arthritis Research UK Pain Centre, Department of Academic Rheumatology, University of Nottingham, Nottingham, UK. mbxsa1@nottingham.ac.uk
Mapp
Paul I
PI
Walsh
David A
DA
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D002351:Carrageenan / Q000008:administration & dosage; D049109:Cell Proliferation / Q000187:drug effects; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D004852:Epoxy Compounds / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000008:administration & dosage; D006614:Hindlimb; D007270:Injections, Intra-Articular; D007596:Joints / Q000187:drug effects / Q000473:pathology; D008264:Macrophages / Q000187:drug effects / Q000473:pathology; D008297:Male; D009389:Neovascularization, Pathologic / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology; D051381:Rats; D017208:Rats, Wistar; D013583:Synovial Membrane / Q000098:blood supply / Q000187:drug effects / Q000473:pathology*; D013585:Synovitis / Q000139:chemically induced / Q000473:pathology* / Q000503:physiopathology; D014633:Valine / Q000031:analogs & derivatives / Q000494:pharmacology
D020533:Angiogenesis Inhibitors; D004852:Epoxy Compounds; C488724:PPI 2458; D016222:Fibroblast Growth Factor 2; D002351:Carrageenan; D014633:Valine